OKA Corporation Bhd (KLSE:OKA)
Malaysia · Delayed Price · Currency is MYR 0.4950
-0.0050 (-1.00%)
At close: Aug 5, 2025
Longboard Pharmaceuticals Income Statement
Financials in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Revenue | 156.37 | 141.12 | 135.79 | 113.72 | 116.12 | Upgrade |
Revenue Growth (YoY) | 10.81% | 3.92% | 19.40% | -2.06% | -2.47% | Upgrade |
Cost of Revenue | 120.11 | 108.7 | 102.72 | 77.91 | 79.28 | Upgrade |
Gross Profit | 36.26 | 32.42 | 33.07 | 35.81 | 36.84 | Upgrade |
Selling, General & Admin | 24.26 | 23.24 | 21.96 | 21.96 | 20.38 | Upgrade |
Other Operating Expenses | -0.26 | -0.66 | -0.97 | -1.28 | -1.41 | Upgrade |
Operating Expenses | 23.81 | 22.79 | 21.31 | 17.72 | 16.21 | Upgrade |
Operating Income | 12.45 | 9.63 | 11.76 | 18.09 | 20.63 | Upgrade |
Interest Expense | -0.01 | -0.02 | -0.01 | -0 | -0 | Upgrade |
Interest & Investment Income | 0.95 | 1.49 | 1.28 | 0.88 | 0.99 | Upgrade |
Currency Exchange Gain (Loss) | 0 | 0.01 | 0.05 | - | - | Upgrade |
EBT Excluding Unusual Items | 13.39 | 11.11 | 13.08 | 18.96 | 21.62 | Upgrade |
Gain (Loss) on Sale of Assets | 0.1 | 0.03 | 0.15 | 0.37 | 0.02 | Upgrade |
Pretax Income | 13.49 | 11.15 | 13.23 | 19.34 | 21.64 | Upgrade |
Income Tax Expense | 3.5 | 1.86 | 2.16 | 4.25 | 5.79 | Upgrade |
Net Income | 9.99 | 9.28 | 11.06 | 15.09 | 15.85 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | -0 | - | - | Upgrade |
Net Income to Common | 9.99 | 9.28 | 11.06 | 15.09 | 15.85 | Upgrade |
Net Income Growth | 7.62% | -16.08% | -26.67% | -4.80% | 40.25% | Upgrade |
Shares Outstanding (Basic) | 245 | 245 | 245 | 245 | 245 | Upgrade |
Shares Outstanding (Diluted) | 245 | 245 | 245 | 245 | 245 | Upgrade |
EPS (Basic) | 0.04 | 0.04 | 0.05 | 0.06 | 0.06 | Upgrade |
EPS (Diluted) | 0.04 | 0.04 | 0.05 | 0.06 | 0.06 | Upgrade |
EPS Growth | 7.62% | -16.08% | -26.67% | -4.81% | 40.25% | Upgrade |
Free Cash Flow | 4.85 | 1.56 | -2.18 | 5.12 | 9.8 | Upgrade |
Free Cash Flow Per Share | 0.02 | 0.01 | -0.01 | 0.02 | 0.04 | Upgrade |
Dividend Per Share | 0.025 | 0.023 | 0.033 | 0.045 | 0.045 | Upgrade |
Dividend Growth | 8.70% | -30.30% | -26.67% | - | 12.50% | Upgrade |
Gross Margin | 23.19% | 22.97% | 24.35% | 31.49% | 31.72% | Upgrade |
Operating Margin | 7.96% | 6.83% | 8.66% | 15.91% | 17.77% | Upgrade |
Profit Margin | 6.39% | 6.58% | 8.15% | 13.27% | 13.65% | Upgrade |
Free Cash Flow Margin | 3.10% | 1.10% | -1.60% | 4.50% | 8.44% | Upgrade |
EBITDA | 15.84 | 12.79 | 14.99 | 21.55 | 24.45 | Upgrade |
EBITDA Margin | 10.13% | 9.06% | 11.04% | 18.95% | 21.06% | Upgrade |
D&A For EBITDA | 3.39 | 3.16 | 3.24 | 3.46 | 3.82 | Upgrade |
EBIT | 12.45 | 9.63 | 11.76 | 18.09 | 20.63 | Upgrade |
EBIT Margin | 7.96% | 6.83% | 8.66% | 15.91% | 17.77% | Upgrade |
Effective Tax Rate | 25.96% | 16.71% | 16.35% | 21.98% | 26.77% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.